SkinMedica appoints new CEO

Ms Fisher was previously COO at Acorda Therapeutics, a biotechnology company. During her seven years at Acorda, she also served as executive vice president of commercial operations and vice president of marketing and strategic planning.

Rex Bright, the current president and CEO of SkinMedica, will continue as president of SkinMedica, and a member of the board of directors, and will also consult closely with Ms Fisher.

Mr Bright, said: “I’m delighted to welcome Mary to SkinMedica. She brings an impressive track record of accomplishment, with over 25 years of pharmaceutical and biotechnology industry experience. Mary is ideally suited to lead company’s continued growth and development in the rapidly expanding dermatology and skincare markets.”